707 related articles for article (PubMed ID: 20494257)
61. Mutation analysis for heterozygote detection and the prenatal diagnosis of cystic fibrosis.
Lemna WK; Feldman GL; Kerem B; Fernbach SD; Zevkovich EP; O'Brien WE; Riordan JR; Collins FS; Tsui LC; Beaudet AL
N Engl J Med; 1990 Feb; 322(5):291-6. PubMed ID: 2296270
[TBL] [Abstract][Full Text] [Related]
62. [Conditions and limitations of healthy carrier screening for the mutation responsible for cystic fibrosis].
Serre JL; Feingold J
Rev Epidemiol Sante Publique; 1993; 41(5):353-62. PubMed ID: 8284475
[TBL] [Abstract][Full Text] [Related]
63. [Non-invasive prenatal diagnosis of cystic fibrosis].
Paterlini Bréchot P; Mouawia H; Saker A
Arch Pediatr; 2011 Jan; 18(1):111-8. PubMed ID: 21177083
[TBL] [Abstract][Full Text] [Related]
64. Cystic fibrosis carrier screening.
Massie J; Delatycki MB
Paediatr Respir Rev; 2013 Dec; 14(4):270-5. PubMed ID: 23466339
[TBL] [Abstract][Full Text] [Related]
65. [Neonatal mass screening for cystic fibrosis in south-east Poland].
Słuszniak A; Kurtyka Z; Lemańska D
Przegl Lek; 2011; 68(1):59-62. PubMed ID: 21563447
[TBL] [Abstract][Full Text] [Related]
66. Carrier screening, incidence of cystic fibrosis, and difficult decisions.
Liou TG; Rubenstein RC
JAMA; 2009 Dec; 302(23):2595-6. PubMed ID: 20009063
[No Abstract] [Full Text] [Related]
67. [Preconceptional carrier screening should not be delayed].
Cornel MC; Lakeman P; Dondorp W
Ned Tijdschr Geneeskd; 2011; 155():A3205. PubMed ID: 21504638
[TBL] [Abstract][Full Text] [Related]
68. Benchmarks for cystic fibrosis carrier screening: a European consensus document.
Castellani C; Macek M; Cassiman JJ; Duff A; Massie J; ten Kate LP; Barton D; Cutting G; Dallapiccola B; Dequeker E; Girodon E; Grody W; Highsmith EW; Kääriäinen H; Kruip S; Morris M; Pignatti PF; Pypops U; Schwarz M; Soller M; Stuhrman M; Cuppens H
J Cyst Fibros; 2010 May; 9(3):165-78. PubMed ID: 20363197
[TBL] [Abstract][Full Text] [Related]
69. Prenatal screening for cystic fibrosis: an early report card.
Palomaki GE
Genet Med; 2004; 6(3):115-6. PubMed ID: 15354327
[No Abstract] [Full Text] [Related]
70. Female cystic fibrosis mutation carriers and assisted reproductive technology: does carrier status affect reproductive outcomes?
VanWort TA; Lee JA; Karvir H; Whitehouse MC; Beim PY; Copperman AB
Fertil Steril; 2014 Nov; 102(5):1324-30. PubMed ID: 25217870
[TBL] [Abstract][Full Text] [Related]
71. Neonatal screening for cystic fibrosis in Brittany, France: assessment of 10 years' experience and impact on prenatal diagnosis.
Scotet V; de Braekeleer M; Roussey M; Rault G; Parent P; Dagorne M; Journel H; Lemoigne A; Codet JP; Catheline M; David V; Chaventré A; Duguépéroux I; Verlingue C; Quéré I; Mercier B; Audrézet MP; Férec C
Lancet; 2000 Sep; 356(9232):789-94. PubMed ID: 11022925
[TBL] [Abstract][Full Text] [Related]
72. Neonatal screening for the cystic fibrosis main mutation delta F508 in Estonia.
Klaassen T; Teder M; Viikmaa M; Metspalu A
J Med Screen; 1998; 5(1):16-9. PubMed ID: 9575453
[TBL] [Abstract][Full Text] [Related]
73. Declining prevalence of cystic fibrosis since the introduction of newborn screening.
Massie J; Curnow L; Gaffney L; Carlin J; Francis I
Arch Dis Child; 2010 Jul; 95(7):531-3. PubMed ID: 20551198
[TBL] [Abstract][Full Text] [Related]
74. New cystic fibrosis genetic tests bring hope and dilemmas.
Arnold C
Lancet Respir Med; 2014 Jan; 2(1):30. PubMed ID: 24461897
[No Abstract] [Full Text] [Related]
75. [The example of cystic fibrosis to highlight the complexity of genetic screening].
Bochud M; Fellmann F; Vader JP; Grosse S; Paccaud F; Guessous I
Rev Med Suisse; 2010 Jul; 6(256):1395-9. PubMed ID: 20701015
[TBL] [Abstract][Full Text] [Related]
76. Carrier screening for cystic fibrosis.
Massie J
Lancet; 2009 Sep; 374(9694):978. PubMed ID: 19766881
[No Abstract] [Full Text] [Related]
77. Longitudinal cystic fibrosis care.
Antunovic SS; Lukac M; Vujovic D
Clin Pharmacol Ther; 2013 Jan; 93(1):86-97. PubMed ID: 23149927
[TBL] [Abstract][Full Text] [Related]
78. Cystic fibrosis newborn screening: a pilot study to maximize carrier screening.
Lagoe E; Labella S; Arnold G; Rowley PT
Genet Test; 2005; 9(3):255-60. PubMed ID: 16225405
[TBL] [Abstract][Full Text] [Related]
79. A Low-Cost and Simple Genetic Screening for Cystic Fibrosis Provided by the Brazilian Public Health System.
Rispoli T; Martins de Castro S; Grandi T; Prado M; Filippon L; Dornelles da Silva CM; Vargas JE; Rossetti LMR
J Pediatr; 2018 Aug; 199():272-277.e3. PubMed ID: 29731357
[TBL] [Abstract][Full Text] [Related]
80. Secondhand Smoke Exposure and Serum Trypsinogen in Cystic Fibrosis Carriers.
Ellery KM; Kopp B; Conwell DL; Gariepy C
Pancreas; 2019 Oct; 48(9):1155-1159. PubMed ID: 31593019
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
